Harry Glorikian’s love letter to the technology industry

It’s the start of the new year and many of you are taking the opportunity to consider new positions in the field. College students will be securing summer internships and May graduates are hoping to land their first job. Undoubtedly, many of you will be looking to Silicon Valley and other major tech hubs across the US, like San Francisco, Boston, New York, and Austin, striving for a position at a top company, such as Google, Amazon, Facebook, or Apple. Or perhaps you’re looking beyond the US borders at international giants like China’s AliBaba. While these and other tech companies, including stalwarts like IBM, Hewlett-Packard, and Microsoft, offer tremendous opportunities to begin (or continue) a career in the field, with complex and intellectually stimulating problems to work on, may I suggest expanding your job search to a different industry? One that has only recently begun to truly embrace technology and where the opportunities are nearly limitless and the impact you can have profound?

To read the full article: http://aiweek.io/healthcare/my-love-letter-to-tech/

About Harry Glorikian

Harry Glorikian is an influential global business expert with more than three decades of experience building successful ventures in North America, Europe, Asia and the rest of the world. Harry is well known for achievements in life sciences, healthcare, diagnostics, healthcare IT and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and be part of innovative concepts and trends.

He is currently a General Partner at New Ventures Funds (NV). Before joining NV Funds, he served as an Entrepreneur In Residence to GE Ventures – New Business Creation Group. He currently serves on the board of GeneNews Ltd. He also serves on the advisory board of Evidation Health (a digital health startup launched with support from GE Ventures), and several other companies. He is also a co-founder and an advisory board member of DrawBridge Health (a revolutionary diagnostics startup launched with support from GE Ventures).

Harry holds an MBA from Boston University and a bachelor’s degree from San Francisco State University. Harry has addressed the NIH, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences, worldwide. He has authored numerous articles, appeared on CBS Evening News and been quoted regularly by Dow Jones, The Boston Globe, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many others.